Holiday Notice: Expect delayed shipping. Orders ship 4/6.
FOR RESEARCH PURPOSES ONLY. NOT FOR HUMAN CONSUMPTION.

TB-500 — Published Research

Reviewed by: Dr. Sarah Chen, PharmD| Last updated: February 24, 2026|For laboratory reference only

← Back to TB-500 product page

Research Library

Published research on thymosin beta-4 — for educational purposes only

Thymosin Beta-4 Actin Sequestration Mechanism

Thymosin beta-4 is the principal G-actin-sequestering peptide in mammalian cells, maintaining the pool of unpolymerized actin monomers. The binding interaction occurs primarily through the central LKKTETQ motif and flanking residues, with a 1:1 stoichiometry and Kd of approximately 0.7 µM. By regulating the G-actin/F-actin equilibrium, Tβ4 modulates actin-dependent cellular processes including motility, division, and morphogenesis. NMR studies reveal that Tβ4 is intrinsically disordered in solution but adopts a helical conformation upon actin binding.

Safer D et al. “Thymosin beta 4 and Fx, an actin-sequestering peptide, are indistinguishable.” J Biol Chem. 1991. PubMed

Tβ4 and Keratinocyte Migration In Vitro

In vitro scratch wound assays using dermal keratinocytes demonstrated that thymosin beta-4 at concentrations of 1–100 ng/mL increased the rate of keratinocyte migration across the wound gap. The migration effect was associated with increased lamellipodial protrusion and was abolished by cytochalasin D (an actin polymerization inhibitor), confirming actin-dependent mechanisms. Boyden chamber assays further demonstrated directed chemotaxis of endothelial cells toward Tβ4 concentration gradients.

Malinda KM et al. “Thymosin beta4 accelerates wound healing.” J Invest Dermatol. 1999. PubMed

Tβ4 in Cardiac Progenitor Cell Research

Epicardial progenitor cell studies in murine models demonstrated that Tβ4 activates Akt signaling in epicardial cells, inducing their mobilization and differentiation. The mechanism involves Tβ4 interaction with integrin-linked kinase (ILK) and PINCH-1 in a complex that activates PI3K/Akt survival signaling. In embryonic heart explant cultures, Tβ4 promoted epicardial cell outgrowth and neovascularization, as measured by von Willebrand factor staining and vessel density quantification.

Smart N et al. “Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.” Nature. 2007. PubMed

Tβ4 Anti-Inflammatory NF-κB Pathway Research

In vitro and in vivo studies have investigated Tβ4’s effects on NF-κB signaling in inflammatory models. In LPS-stimulated macrophage cultures, Tβ4 reduced nuclear translocation of NF-κB p65 and decreased production of pro-inflammatory cytokines TNF-α and IL-1β in a concentration-dependent manner. Corneal injury models in mice demonstrated that topical Tβ4 application reduced neutrophil infiltration and MMP-9 expression, with the anti-inflammatory effects mediated through suppression of the NF-κB/IκBα pathway.

Sosne G et al. “Thymosin beta 4 suppresses LPS-induced NF-κB activation in corneal epithelial cells.” Exp Eye Res. 2007. PubMed

Disclaimer: All research citations are provided for educational purposes only. These references describe findings from in vitro and animal model studies. This information does not constitute medical advice and should not be interpreted as endorsement of any specific application.

Reviewed by

Dr. Sarah Chen, PharmD

Research pharmacologist specializing in peptide therapeutics. Reviews published clinical data and pharmacological research for accuracy and completeness.

Editorial Review

Reviewed by Dr. Sarah Chen, PharmD and Dr. James Porter, PhD — Panda Peptides Research Team.

Last reviewed: April 2026.

This content summarizes published peer-reviewed research for educational purposes only. It is not medical advice and does not constitute a recommendation for any specific compound or protocol.